BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan · Delayed Price · Currency is JPY 65.00
-1.00 (-1.52%)
At close: Apr 17, 2026
TYO:4594 Revenue
BrightPath Biotherapeutics had revenue of 1.08M JPY in the twelve months ending December 31, 2025, up 1,395.83% year-over-year. In the fiscal year ending March 31, 2025, BrightPath Biotherapeutics had annual revenue of 1.13M with 1,473.61% growth.
Revenue (ttm)
1.08M
Revenue Growth
+1,395.83%
P/S Ratio
8,155.62
Revenue / Employee
25.64K
Employees
42
Market Cap
8.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.13M | 1.06M | 1,473.61% |
| Mar 31, 2024 | 72.00K | -353.93M | -99.98% |
| Mar 31, 2018 | 354.00M | -175.00M | -33.08% |
| Mar 31, 2017 | 529.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition